Published on in Vol 7, No 11 (2021): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29319, first published .
Association of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Cross-sectional Web-Based Survey

Association of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Cross-sectional Web-Based Survey

Association of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Cross-sectional Web-Based Survey

Journals

  1. Hyun W, Son Y, Jung S. Infection preventive behaviors and its association with perceived threat and perceived social factors during the COVID-19 pandemic in South Korea: 2020 community health survey. BMC Public Health 2022;22(1) View
  2. Bonnet U, Specka M, Roser P, Scherbaum N. Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review. Journal of Neural Transmission 2023;130(1):7 View
  3. Morgan K, Maglalang D, Monnig M, Ahluwalia J, Avila J, Sokolovsky A. Medical Mistrust, Perceived Discrimination, and Race: a Longitudinal Analysis of Predictors of COVID-19 Vaccine Hesitancy in US Adults. Journal of Racial and Ethnic Health Disparities 2023;10(4):1846 View
  4. Goodyear K, Moyo P, Avila J, Ahluwalia J, Monnig M. Associations between alcohol and cannabis use before and during the COVID-19 pandemic: Results of a community survey. Addictive Behaviors Reports 2022;16:100455 View
  5. Strathdee S, Abramovitz D, Harvey-Vera A, Vera C, Rangel G, Artamonova I, Chaillon A, Ignacio C, Calderon A, Martin N, Patterson T, Page K. Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region. PLOS ONE 2021;16(11):e0260286 View
  6. Fond G, Yon D, Boyer L. One-year results from the vaccination campaign against COVID-19 infection in 47 million individuals with severe mental disorders and other chronic diseases. European Archives of Psychiatry and Clinical Neuroscience 2023;273(2):517 View
  7. Huang C, Wei Y, Yan V, Ye X, Kang W, Yiu H, Shami J, Cowling B, Tse M, Castle D, Chui C, Lai F, Li X, Wan E, Wong C, Hayes J, Chang W, Chung A, Lau C, Wong I, Chan E. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study. The Lancet Psychiatry 2023;10(6):403 View
  8. Specka M, Kröckert T, Trilling M, Bonnet U, Schifano F, Scherbaum N. Opiate maintenance patients’ attitudes and self-reported adherence to protective measures against SARS-CoV-2 infections. Frontiers in Psychiatry 2023;14 View
  9. Miguez F, Oliveira G, Enriquez-Martinez O, Fonseca M, Griep R, Barreto S, Molina M. Fatores associados à adesão a comportamentos preventivos da COVID-19 em participantes do ELSA-Brasil. Cadernos de Saúde Pública 2023;39(8) View
  10. Monnig M, Clark S, Treloar Padovano H, Sokolovsky A, Goodyear K, Ahluwalia J, Monti P. Access to medication for opioid use disorder supported by telemedicine and healthcare coverage: A web-based survey during the COVID-19 pandemic. Addictive Behaviors Reports 2023;18:100515 View
  11. Strathdee S, Abramovitz D, Harvey-Vera A, Stamos-Buesig T, Vera C, Artamonova I, Logan J, Patterson T, Servin A, Bazzi A. A Brief Peer-Led Intervention to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs in San Diego County: Results From a Pilot Randomized Controlled Trial. Open Forum Infectious Diseases 2023;10(8) View
  12. Gully B, Padovano H, Clark S, Muro G, Monnig M. Exposure to the Death of Others during the COVID-19 Pandemic: Growing Mistrust in Medical Institutions as a Result of Personal Loss. Behavioral Sciences 2023;13(12):999 View
  13. Khanna A, Monnig M, Clark S, Monti P. Social network characteristics of COVID-19 vaccination and preventive health behaviors: Cross-sectional findings from the US northeast during the early COVID-19 pandemic. Vaccine: X 2024;21:100577 View